167 related articles for article (PubMed ID: 11197561)
1. Effects of anti-inflammatory drugs on lipopolysaccharide-challenged and -unchallenged equine synovial explants.
Moses VS; Hardy J; Bertone AL; Weisbrode SE
Am J Vet Res; 2001 Jan; 62(1):54-60. PubMed ID: 11197561
[TBL] [Abstract][Full Text] [Related]
2. In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.
Brideau C; Van Staden C; Chan CC
Am J Vet Res; 2001 Nov; 62(11):1755-60. PubMed ID: 11703020
[TBL] [Abstract][Full Text] [Related]
3. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.
Beretta C; Garavaglia G; Cavalli M
Pharmacol Res; 2005 Oct; 52(4):302-6. PubMed ID: 15939622
[TBL] [Abstract][Full Text] [Related]
4. Effects of flunixin, tolfenamic acid, R(-) and S(+) ketoprofen on the response of equine synoviocytes to lipopolysaccharide stimulation.
Landoni MF; Foot R; Frean S; Lees P
Equine Vet J; 1996 Nov; 28(6):468-75. PubMed ID: 9049496
[TBL] [Abstract][Full Text] [Related]
5. In vitro effects of nonsteroidal anti-inflammatory drugs on cyclooxygenase activity in dogs.
Kay-Mugford P; Benn SJ; LaMarre J; Conlon P
Am J Vet Res; 2000 Jul; 61(7):802-10. PubMed ID: 10895904
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B.
Bryant CE; Farnfield BA; Janicke HJ
Am J Vet Res; 2003 Feb; 64(2):211-5. PubMed ID: 12602591
[TBL] [Abstract][Full Text] [Related]
7. In vivo effects of meloxicam and aspirin on blood, gastric mucosal, and synovial fluid prostanoid synthesis in dogs.
Jones CJ; Streppa HK; Harmon BG; Budsberg SC
Am J Vet Res; 2002 Nov; 63(11):1527-31. PubMed ID: 12428662
[TBL] [Abstract][Full Text] [Related]
8. Measurement of cyclooxygenase inhibition in vivo: a study of two non-steroidal anti-inflammatory drugs in sheep.
Cheng Z; Nolan AM; McKellar QA
Inflammation; 1998 Aug; 22(4):353-66. PubMed ID: 9675607
[TBL] [Abstract][Full Text] [Related]
9. Effects of meloxicam, compared with other NSAIDs, on cartilage proteoglycan metabolism, synovial prostaglandin E2, and production of interleukins 1, 6 and 8, in human and porcine explants in organ culture.
Rainsford KD; Ying C; Smith FC
J Pharm Pharmacol; 1997 Oct; 49(10):991-8. PubMed ID: 9364409
[TBL] [Abstract][Full Text] [Related]
10. Effects of the omega-3 fatty acid, alpha-linolenic acid, on lipopolysaccharide-challenged synovial explants from horses.
Munsterman AS; Bertone AL; Zachos TA; Weisbrode SE
Am J Vet Res; 2005 Sep; 66(9):1503-8. PubMed ID: 16261822
[TBL] [Abstract][Full Text] [Related]
11. Preferential inhibition of cyclooxygenase-2 by meloxicam in human rheumatoid synoviocytes.
Tsubouchi Y; Sano H; Yamada R; Hashiramoto A; Kohno M; Kusaka Y; Kondo M
Eur J Pharmacol; 2000 May; 395(3):255-63. PubMed ID: 10812057
[TBL] [Abstract][Full Text] [Related]
12. Effects of hyaluronan alone or in combination with chondroitin sulfate and N-acetyl-d-glucosamine on lipopolysaccharide challenge-exposed equine fibroblast-like synovial cells.
Kilborne AH; Hussein H; Bertone AL
Am J Vet Res; 2017 May; 78(5):579-588. PubMed ID: 28441052
[TBL] [Abstract][Full Text] [Related]
13. Effects of anti-arthritis preparations on gene expression and enzyme activity of cyclooxygenase-2 in cultured equine chondrocytes.
Tung JT; Venta PJ; Eberhart SW; Yuzbasiyan-Gurkan V; Alexander L; Caron JP
Am J Vet Res; 2002 Aug; 63(8):1134-9. PubMed ID: 12171167
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs affect the mammary epithelial barrier during inflammation.
Sintes GF; Bruckmaier RM; Wellnitz O
J Dairy Sci; 2020 Nov; 103(11):10742-10753. PubMed ID: 32896404
[TBL] [Abstract][Full Text] [Related]
15. Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharide.
Ríos DL; López C; Álvarez ME; Samudio IJ; Carmona JU
BMC Musculoskelet Disord; 2015 Jun; 16():153. PubMed ID: 26092588
[TBL] [Abstract][Full Text] [Related]
16. The effects of a newly developed nonsteroidal anti-inflammatory drug (M-5011) on arachidonic acid metabolism in rheumatoid synovial fibroblasts.
Tobetto K; Yamamoto Y; Kataoka M; Ando T; Sugimoto K; Himeno M
Jpn J Pharmacol; 1997 Dec; 75(4):371-9. PubMed ID: 9469643
[TBL] [Abstract][Full Text] [Related]
17. Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis.
Morton AJ; Campbell NB; Gayle JM; Redding WR; Blikslager AT
Res Vet Sci; 2005 Apr; 78(2):189-92. PubMed ID: 15563928
[TBL] [Abstract][Full Text] [Related]
18. Participation of cyclooxygenase-1 in prostaglandin E2 release from synovitis tissue in primary osteoarthritis in vitro.
Knorth H; Dorfmüller P; Lebert R; Schmidt WE; Wittenberg RH; Heukamp M; Wiese M; Willburger RE
Osteoarthritis Cartilage; 2004 Aug; 12(8):658-66. PubMed ID: 15262246
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
